COVID-19 Vaccine Effectiveness at a Referral Hospital in Northern Peru: A Retrospective Cohort Study

COVID-19 vaccines have achieved a significant reduction in mortality, yet objective estimates are needed in specific settings. We aimed to determine the effectiveness of COVID-19 vaccination at a referral hospital in Lambayeque, Peru. We conducted a retrospective cohort study from February to September 2021. We included hospitalized patients with COVID-19, whose data were stored in NotiWeb, a patient data system of the Peruvian Ministry of Health. We applied a propensity score-weighting method according to baseline characteristics of patients, and estimated hazard ratios (HR) using Cox regression models. Of 1553 participants, the average age was 55 years (SD: 16.8), 907 (58%) were male, and 592 (38%) deceased at 28-day follow-up. Before hospital admission, 74 (4.8%) had been immunized with at least one vaccine dose. Effectiveness against death in vaccinated patients was 50% at 90-day follow-up (weighted HR 0.50, 95% CI 0.28–0.89). Our results support the effectiveness of COVID-19 vaccination against death and provide information after early immunization in Peru.

[1]  Heber Silva-Díaz,et al.  Diversidad genómica en SARS-CoV-2: Mutaciones y variantes , 2021, Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo.

[2]  Shigui Yang,et al.  Impact of Coinfection With SARS-CoV-2 and Influenza on Disease Severity: A Systematic Review and Meta-Analysis , 2021, Frontiers in Public Health.

[3]  R. Arbel,et al.  BNT162b2 Vaccine Booster and Mortality Due to Covid-19 , 2021, The New England journal of medicine.

[4]  M. Abu-Farha,et al.  Robust Antibody Levels in Both Diabetic and Non-Diabetic Individuals After BNT162b2 mRNA COVID-19 Vaccination , 2021, Frontiers in Immunology.

[5]  Michael I. Mandel,et al.  Waning Immunity after the BNT162b2 Vaccine in Israel , 2021, The New England journal of medicine.

[6]  M. Hernán,et al.  Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study , 2021, The Lancet.

[7]  P. Dormitzer,et al.  Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months , 2021, The New England journal of medicine.

[8]  William F. Fadel,et al.  Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings , 2021, The New England journal of medicine.

[9]  Yu Sun,et al.  Effectiveness of the WHO-Authorized COVID-19 Vaccines: A Rapid Review of Global Reports till 30 June 2021 , 2021, medRxiv.

[10]  Raju Vaishya,et al.  Lack of vaccination and associated comorbidities predispose to the need for intensive care in individuals infected with the delta variant – A case cohort study from a tertiary care hospital in New Delhi, India , 2021, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

[11]  Catalina Pírez,et al.  Inmunizaciones como estrategia de salud pública , 2021 .

[12]  A. Lenzi,et al.  Central obesity, smoking habit, and hypertension are associated with lower antibody titres in response to COVID‐19 mRNA vaccine , 2021, Diabetes/metabolism research and reviews.

[13]  I. Hung,et al.  Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster , 2021, The Lancet.

[14]  S. Vollmer,et al.  The disproportionate excess mortality risk of COVID-19 in younger people with diabetes warrants vaccination prioritisation , 2021, Diabetologia.

[15]  P. Dormitzer,et al.  Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine , 2020, The New England journal of medicine.

[16]  Wenling Wang,et al.  Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial , 2020, The Lancet Infectious Diseases.

[17]  S. Flasche,et al.  Use of seasonal influenza and pneumococcal polysaccharide vaccines in older adults to reduce COVID-19 mortality , 2020, Vaccine.

[18]  Jessica M Franklin,et al.  Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners , 2019, BMJ.

[19]  E. Stuart,et al.  Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies , 2015, Statistics in medicine.

[20]  M. Fernández,et al.  Impact of Obesity and Metabolic Syndrome on Immunity. , 2016, Advances in nutrition.